Monday, June 25, 2018

Don't Blame FAANGs for Tech Looking So Expensive, Bernstein Says

LISTEN TO ARTICLE 1:21 SHARE THIS ARTICLE Facebook Twitter LinkedIn Email

Last year, a handful of large-cap tech stocks were responsible for most of the valuation expansion in the sector. A different pattern is playing out this year.

High flyers like Amazon.com Inc. and Nvidia Corp. are still handling most of the sector’s outperformance, but what is different this year is that the 10 biggest companies on average are seeing their earnings multiples shrink. It was “primarily the non-FANG stocks that became more expensive,” Bernstein analysts including Toni Sacconaghi said in a research note.

#lazy-img-328831036:before{padding-top:56.25%;}

On a market cap-weighted basis, the earnings multiples of the 10 largest tech companies in the sector have contracted by 2 percentage points this year, data from Bernstein’s quant team show. At the same time, the sector’s broad-based multiple expansion in 2018 has pushed the sector to trade at 1.18 times the market’s price to forward earnings, the highest among its industry peers.

Still, the sector that has advanced 11 percent this year compared with a 2 percent gain in the broader market is a buying opportunity to Bernstein. The bias is now toward value over growth.

“For the first time in years, tech has become meaningfully more expensive,” the analysts said. “We continue to recommend both a modest overweight in tech and a balanced barbell between growth and value… although our bias is to add selectively to the value side of the barbell.”

Sunday, June 24, 2018

Tandem Diabetes Keeps Rolling Out the Hits

Tandem Diabetes Care Inc. (NASDAQ: TNDM) shares made a solid gain early on Friday after the firm announced a key approval from the U.S. Food and Drug Administration (FDA).

As we have said before, FDA approvals have the potential to make or break companies, and so far this year Tandem just seems to keep rolling out the hits. This company has absolutely rocked the health care sector and is up over 760% in 2018 alone.

The FDA announced the approval of the t:slim X2 Insulin Pump with Basal-IQ technology, a predictive low glucose suspend feature designed to help reduce the frequency and duration of low glucose events (hypoglycemia).

Note that this is the first automated insulin delivery system approved for use by children as young as six years old, and the first insulin pump designated as compatible with integrated continuous glucose monitoring (iCGM) devices.

The company plans to launch its new product with Dexcom G6 continuous glucose monitoring (CGM) integration, which requires no fingersticks for calibration or diabetes treatment decisions and was the first CGM device to receive the iCGM designation from the FDA earlier this year.

Tandem expects the t:slim X2 Pump with Basal-IQ technology to be available in August 2018, and all in-warranty t:slim X2 users in the United States will have the option to add the new feature free of charge via remote software update.

What��s interesting about Tandem��s Basal-IQ algorithm is that it is designed to look 30 minutes into the future to predict where glucose levels are heading. The device suspends insulin delivery when low glucose is predicted, then automatically resumes insulin delivery once glucose levels begin to rise.

Shares of Tandem were last seen up about 12% at $22.82, with a consensus analyst price target of $14.75 and a 52-week range of $2.14 to $25.50.

ALSO READ: 12 American Companies That Control Tech

Wednesday, June 20, 2018

Top Financial Stocks To Invest In 2019

tags:HCCI,MRK,NEU,

U.S. equities suffered a wild ride on Wednesday, initially surging higher thanks to a stronger-than-expected payroll report — lifting expectations for Friday’s jobs figures.

ADP reported 263,000 jobs created in March versus 170,000 expected, and even exceeding the 245,000 reported for February. But then, the release of hawkish minutes from the Federal Reserve’s March meeting crushed sentiment, pushing large-caps into the red on concerns policymakers are worried about lofty financial asset valuations (read: stocks are too expensive and bubbly) and could thus start normalizing their $4.5 trillion balance sheet before the end of the year.

As a reminder, before the financial crisis, the Fed’s balance sheet totaled around $1 trillion. Bringing it back to normal, by allowing asset purchased during multiple rounds of quantitative easing, will quickly dry up liquidity in the capital markets.

In the end, the Dow Jones Industrial Average lost 0.2%, the S&P 500 lost 0.3%, the Nasdaq Composite lost 0.6% and the Russell 2000 lost 1.2%. Treasury bonds were stronger, the dollar was weaker, gold lost 0.8% despite the risk-off dynamic in play and crude oil couldn’t hold early strength and finished lower.

Top Financial Stocks To Invest In 2019: Heritage-Crystal Clean, Inc.(HCCI)

Advisors' Opinion:
  • [By Max Byerly]

    Get a free copy of the Zacks research report on Heritage Crystal Clean (HCCI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Heritage-Crystal Clean (HCCI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Financial Stocks To Invest In 2019: Merck & Company, Inc.(MRK)

Advisors' Opinion:
  • [By Paul Ausick]

    The Dow stock posting the largest daily percentage gain ahead of the close Wednesday was Merck & Co. Inc. (NYSE: MRK) which traded up about 2.55% at $55.12. The stock’s 52-week range is $52.97 to $66.41. Volume was about 30% below the daily average of around 13 million. The company had no specific news.

  • [By Shane Hupp]

    Cobblestone Capital Advisors LLC NY decreased its holdings in Merck & Co. (NYSE:MRK) by 1.1% in the first quarter, Holdings Channel reports. The fund owned 186,306 shares of the company’s stock after selling 2,090 shares during the period. Merck & Co. accounts for approximately 1.0% of Cobblestone Capital Advisors LLC NY’s investment portfolio, making the stock its 26th largest holding. Cobblestone Capital Advisors LLC NY’s holdings in Merck & Co. were worth $10,148,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Keith Speights]

    All three of these apply to Pfizer (NYSE:PFE), but they also all apply to Merck (NYSE:MRK). Both pharmaceutical companies have successful�products with sizzling sales, but both have experienced headwinds that have weighed on their�overall revenue and earnings growth.�

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Merck & Co. (MRK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Financial Stocks To Invest In 2019: NewMarket Corporation(NEU)

Advisors' Opinion:
  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on NewMarket (NEU)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Neumark (CURRENCY:NEU) traded down 1.5% against the U.S. dollar during the one day period ending at 10:00 AM E.T. on June 8th. In the last seven days, Neumark has traded up 3.6% against the U.S. dollar. One Neumark token can now be purchased for about $0.39 or 0.00005083 BTC on popular exchanges including EtherDelta (ForkDelta), YoBit, Liqui and HitBTC. Neumark has a total market cap of $11.07 million and approximately $118,143.00 worth of Neumark was traded on exchanges in the last day.

Friday, June 1, 2018

Financial Contrast: Echelon (ELON) and Lantronix (LTRX)

Echelon (NASDAQ: ELON) and Lantronix (NASDAQ:LTRX) are both small-cap computer and technology companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, earnings, profitability, institutional ownership, dividends and analyst recommendations.

Analyst Ratings

Get Echelon alerts:

This is a summary of current ratings for Echelon and Lantronix, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Echelon 0 0 0 0 N/A
Lantronix 0 0 0 0 N/A

Insider and Institutional Ownership

25.9% of Echelon shares are held by institutional investors. Comparatively, 14.9% of Lantronix shares are held by institutional investors. 13.0% of Echelon shares are held by company insiders. Comparatively, 52.4% of Lantronix shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Valuation and Earnings

This table compares Echelon and Lantronix’s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Echelon $31.67 million 0.63 -$4.62 million ($1.04) -4.22
Lantronix $44.73 million 1.33 -$270,000.00 N/A N/A

Lantronix has higher revenue and earnings than Echelon.

Profitability

This table compares Echelon and Lantronix’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Echelon -15.15% -21.24% -15.49%
Lantronix -0.28% 4.78% 3.28%

Volatility and Risk

Echelon has a beta of -0.74, meaning that its share price is 174% less volatile than the S&P 500. Comparatively, Lantronix has a beta of -0.13, meaning that its share price is 113% less volatile than the S&P 500.

Summary

Lantronix beats Echelon on 9 of the 10 factors compared between the two stocks.

Echelon Company Profile

Echelon Corporation develops, markets, and sells embedded components, modules, edge servers, and software. The company offers chips, gateways, and design and management software to original equipment manufacturers under the LONWORKS and IzoT brands. It also provides a range of control networking solutions under the LumInsight and Lumewave by Echelon brands that consist of wired and wireless control nodes; smart gateways for interconnecting the control nodes; and a software-based Central Management System, which is used for startup, commissioning, management, and monitoring of the lighting network. The company markets its products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific/Japan through direct sales organization, third-party electronics representatives, value-added resellers, and distributors. Echelon Corporation was founded in 1988 and is headquartered in Santa Clara, California.

Lantronix Company Profile

Lantronix, Inc. provides secure data access and management solutions for Internet of Things (IoT) assets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific Japan. The company's IoT products include IoT gateways, which provide secure connectivity and the ability to add integrated device management and advanced data access features; and IoT building blocks that offer basic secure machine connectivity and unmanaged data access. It also offers information technology (IT) management products, which comprise console management, power management, and keyboard video mouse products that offer remote access to IT and networking infrastructure deployed in test labs, data centers, and server rooms; and xPrintServer. The company provides its IT management product line and external IoT solutions through value added resellers, systems integrators, distributors, consumers, online retailers, IT resellers, corporate customers, and government entities, e-tailers, original design manufacturers, and original equipment manufacturers. Lantronix, Inc. was founded in 1989 and is headquartered in Irvine, California.